10x Genomics v Curio Bioscience (CFI, 20 February 2025)
| Date | 20 February 2025 |
|---|---|
| Court | CFI |
| Division | Düsseldorf (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_2588/2025 · ORD_3005/2025 |
| Parties | 10x Genomics, Inc. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By procedural order of 20 February 2025 (UPC_CFI_463/2023, ACT_590953/2023, App_2588/2025), the judge-rapporteur of the Düsseldorf Local Division (Presiding Judge Thomas) ordered the Registry to repay to 10x Genomics the EUR 2,000,000 security deposited for enforcement of the provisional measures granted on 30 April 2024 against Curio Bioscience (EP 2 697 391), a bank guarantee having since been provided. The order confirms that a party may replace a cash deposit with a bank guarantee.
Question
Can an applicant that lodged enforcement security as a cash deposit obtain its repayment after providing a bank guarantee?
Decision
Yes. Following Ortovox v Mammut, Düsseldorf Local Division, 5 August 2024, the judge-rapporteur held that the resulting double security can justify a corresponding release, although the applicant’s choice is not unlimited and must be weighed against the interests of the applicant, the defendant and the court. 10x Genomics had a legitimate interest in depositing cash first, so as to enforce the measures promptly, since a bank guarantee could not be obtained as quickly, its US bank not being directly supervised by the ECB. The deposit being economically disadvantageous and the bank guarantee, delivered on 19 December 2024, duly provided, the Registry must repay the sum (Rule 352.2 and Rule 45.3 of the Registry Rules), but only once the time limit for requesting panel review (Rule 333.2) has expired without a request. Curio Bioscience had not commented.
Key points for practice
- A cash deposit can serve as a stopgap to allow immediate enforcement, then be replaced by a bank guarantee.
- Practical point: an application for repayment should explain why the original form of security was chosen and prove that the replacement guarantee has been duly provided.
Provisions applied
- Rules of Procedure
- Rules 333.2, 352.2 and 354.1
- Case law cited
- Ortovox v Mammut, Düsseldorf Local Division, 5 August 2024 (UPC_CFI_452/2023).
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimant10x Genomics, Inc.57 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- Le greffe doit restituer la garantie de 2 000 000 euros consignée, une garantie bancaire ayant été remise, sous réserve de l'expiration du délai de révision.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 697 391mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Ortovox Sportartikel v Mammut Sports Group (CFI, 5 August 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 697 391Method and product for localised or spatial detection of nucleic acid in a tissue sample recorded proprietor: Spatial Transcriptomics AB | Mentioned in the analysis (role not qualified) Also mentioned in 28 other decision(s): 10x Genomics v Curio Bioscience (CFI, ORD_598272/2023, 30 April 2024) · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_658/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_657/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, 5 August 2025) · 10x Genomics v Curio Bioscience (CFI, 4 August 2025) · 10x Genomics v Curio Bioscience (CFI, 16 June 2025) · 10x Genomics v Curio Bioscience (CFI, 4 June 2025) · 10x Genomics v Curio Bioscience (CFI, 2 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.